Solvay S.A.

Solvay S.A.

SOLB.BR
Solvay S.A.BE flagEuronext Brussels
26.16
EUR
-0.06
- -
2.73BMarket Cap
Solvay S.A.
SOLB.BR
(Euronext Brussels)

Recent

price

26.16

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
68.87
87.51
124.58
114.71
127.71
120.4
97.24
106.28
109.41
108.81
94.18
110.45
76.9
57.84
48.86
45.43
44.45
Revenue per Share
21.07
2.86
6.43
3.05
0.96
4.85
6.01
10.27
8.49
1.14
-9.33
9.16
18.36
20.09
2.12
0.29
-0.25
Basic EPS, GAAP
3.52
2.87
16.64
4.88
7.62
3.01
7.81
7.43
8.59
9.29
6.85
8.34
10.57
8.13
3.14
4.42
4.25
Free Cash Flow per Basic Share
2.87
3.08
3.17
3.88
3.5
3.86
3.74
3.83
3.98
4.13
4.06
4.16
4.02
4.07
2.48
2.5
2.43
Dividend per Share
14.69
14.71
82.99
82.01
84.39
87.27
72.48
77.81
81.55
78.02
63.73
68.15
81.37
18.43
18.57
16.57
2.27
Book Value per Share
75.46
26.75
27.34
30.92
25.03
-1.09
6.56
17.15
25.1
24.38
18.38
32.53
49.58
3.27
3.85
1.22
2.07
Tangible Book Value per Share
87
86
88
88
83
84
103
103
103
103
103
104
104
104
105
104
104
Basic Weighted Avg Shares
5,959
7,563
10,910
10,149
10,629
10,082
10,044
10,984
11,299
11,227
9,714
11,435
7,978
6,025
5,130
4,746
4,645
Sales/Revenue/Turnover
9.58
7.19
8.02
7.01
8.98
8.67
9.51
10.39
10.78
10.57
8.69
10.59
10.05
13.59
12.69
10.03
9.54
Operating Margin (%)
607
455
794
872
1,430
783
1,025
1,152
921
1,032
2,416
849
923
994
362
404
404
Depreciation Expense
1,823
247
563
270
80
406
621
1,061
877
118
-962
948
1,905
2,093
223
30
-26
Net Income, GAAP
- -
6.03
29.39
44.97
24.49
14.62
- -
- -
9.48
206.76
- -
10.05
20.14
115.56
27.19
76.43
123.81
Effective Tax Rate (%)
30.59
3.27
5.16
2.66
0.75
4.03
6.18
9.66
7.76
1.05
-9.9
8.29
23.88
34.74
4.35
0.63
-0.56
Profit Margin (%)
6,310
2,758
3,198
3,162
1,336
2,282
1,596
1,929
2,672
2,181
1,709
1,302
2,125
522
563
311
404
Working Capital
2,535
3,374
3,321
2,809
1,485
5,628
4,087
2,900
2,971
3,227
3,117
2,520
2,407
243
1,728
1,800
1,830
LT Debt
6,708
6,648
6,573
7,452
6,778
9,668
9,957
9,754
10,626
9,624
7,303
8,851
10,664
1,306
1,404
1,082
1,181
Total Equity
- -
5.03
5.85
3.66
6.98
5.77
- -
- -
7.79
-8.88
- -
9.38
4.93
-1.66
18.5
3.33
-2.96
Return on Invested Capital (%)
- -
7.72
9.31
3.35
3.69
4.31
- -
- -
8.49
-1.51
- -
9.77
17.56
29.93
9.68
1.34
-2.51
Return on Capital (%)
143.43
19.43
13.19
3.72
1.12
5.67
8.39
13.66
10.65
1.43
-13.16
13.91
24.59
40.4
11.52
1.63
-10.97
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
161
331
366
LT Borrowings
2,047
1,494
1,830
LT Finance Leases
- -
306
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
104
104
104
Market Capitalization
2,823
2,837
2,765

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
2,201
2,156
2,190
Cash, Cash Equivalents & STI
426
555
501
Accounts Receivable, Net
703
622
678
Inventories
578
587
592
Total Current Liabilities
1,558
1,845
1,786
Payables & Accruals
- -
- -
- -
ST Debt
161
331
366
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-8.52%
-12.3%
-22.93%
Free Cash Flow
21.8%
1.07%
40%
Net Income, GAAP
-115.9%
-52.72%
-86.55%
Sales/Revenue/Turnover
-6.16%
-11.87%
-7.49%
Total Cash Common Dividend
-0.91%
-7.4%
0.38%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,298
1,333
1,245
1,254
5,130
2025
1,243
1,212
1,196
1,095
4,746
2026
1,142
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.02
0.64
0.18
0.29
2.12
2025
0.78
0.09
0.33
-0.91
0.29
2026
0.25
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.62
0.82
- -
- -
2.48
2025
0.97
1.46
- -
- -
2.5
2026
0.97
- -
- -
- -
- -
Business
Solvay S.A. Solvay SA is a Belgium-based chemical company focused on the production and sale of essential chemicals serving resilient global markets including consumer goods, healthcare, food, electronics, building and construction, automotive, and industrial applications. Founded in 1863 and headquartered in Brussels, the company operates manufacturing facilities in approximately 40 countries across Europe, North America, Latin America, and Asia, employing over 9,000 people; its core portfolio comprises Basic Chemicals such as soda ash and derivatives, sodium bicarbonate, hydrogen peroxide, and Peroxides, alongside Performance Chemicals including highly dispersible silica, Coatis products, Special Chem formulations, solvents, fluorine, rare earths, and phenol, produced through proprietary large-scale processes with vertical integration and customization capabilities. Following the partial demerger completed on December 9, 2023, which separated its specialty chemicals activities into the standalone entity Syensqo, Solvay streamlined into a more focused essential chemicals provider with a new strategy emphasizing operational excellence, process innovation, energy transition toward carbon neutrality by 2050, and capacity expansions in high-growth areas like electronic grade peroxide, circular silica, and rare earths; recent initiatives include portfolio realignment at its Bad Wimpfen site in Germany announced in September 2025 to establish a global hub for Nocolok production with €25 million in investments planned primarily for 2026, ongoing share buyback programs such as the completion of a 1.025 million share repurchase in October 2024 and further acquisitions in March 2025 to support long-term incentive plans, and structural cost savings alongside disciplined investments amid a challenging market environment reflected in Q3 2025 underlying net sales of €1,044 million.